Extended thromboprophylaxis with aspirin noninferior to dalteparin for THA patients
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trialAnn Intern Med. 2013 Jun 4;158(11):800-6. doi: 10.7326/0003-4819-158-11-201306040-00004
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
786 total hip arthroplasty (THA) patients were administered daily subcutaneous injections containing low-molecular-weight heparin (dalteparin) for 10 days, starting the next morning after surgery. Afterwards, patients were randomized to receive dalteparin injections in combination with placebo aspirin tablets or receive aspirin tablets combined with placebo dalteparin injections for 28 days, to co...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE